rPeptide

Founded in 1999, rPeptide provides high-quality research-grade solutions for academic and industry researchers. With a focus on neurodegenerative disease research, including Alzheimer’s and Parkinson’s, and a portfolio of recombinant peptides, proteins, antibodies, fibrils, and custom services, rPeptide is committed to improving scientific understanding and enabling breakthroughs in neurological disorders, striving towards a better tomorrow together.  

Cambridge Bioscience is pleased to provide rPeptide products in the UK and Ireland.